AstraZeneca (HAM:ZEG) Net Interest Margin (Bank Only) %


HAM:ZEG AstraZeneca PLC HAM:ZEG
87 GF Score
Price €166.40
GF Value €156.90
Valuation Fairly Valued
! 4 Warning Signs
View Full Analysis

What is AstraZeneca Net Interest Margin (Bank Only) %?

Net Interest Margin (Bank Only) % only applies to banks.

HAM:ZEG
87GF Score
AstraZeneca PLC HAM:ZEG
Net Interest Margin (Bank Only) % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is AstraZeneca (HAM:ZEG) Overvalued in 2026?

Based on GuruFocus' analysis, AstraZeneca stock appears to be overvalued. The current stock price of €166.40 is trading 6.1% above its estimated GF Value™ of €156.90. GuruFocus considers AstraZeneca to be Fairly Valued.

Key valuation signals for HAM:ZEG:

  • Net Interest Margin (Bank Only) %:
  • GF Value™: €156.90 vs. price of €166.40 (6.1% above fair value)
  • GF Score™: 87/100 with 4 warning signs

No single metric tells the full story. See the HAM:ZEG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

AstraZeneca Business Description

Address 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge, GBR, CB2 0AA
A merger between Astra of Sweden and Zeneca of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (over 40% of total revenue), cardiovascular, renal, and metabolic (over 20%), rare disease (16%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States representing close to one-third of its sales.
87GF Score

Get the complete analysis for HAM:ZEG

Net Interest Margin (Bank Only) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€166.40
Price
€156.90
GF Value